Abstract
We assumed that diabetic encephalopathy (DEP) may be induced by endoplasmic reticulum (ER)-mediated inflammation and apoptosis in central nervous system. To test this notion, here we investigated the neuronal ER stress and associated inflammation and apoptosis in a type 2 diabetes model induced with high-fat diet/streptozotocin in Sprague-Dawley rats. Elevated expressions of ER stress markers, including glucose-regulated protein 78 (GRP78), activating transcription factor-6 (ATF-6), X-box binding protein-1 (XBP-1), and C/EBP homologous protein, and phosphor-Jun N-terminal kinase (p-JNK) were evident in the hippocampus CA1 of diabetic rats. These changes were also accompanied with the activation of NF-κB and the increased levels of inflammatory cytokines, tumor necrosis factor-α (TNF-α) and Interleukin-6 (IL-6). Mechanistic study with in vitro cultured hippocampus neurons exposed to high glucose (HG), which induced a diabetes-like effects, shown by increased ER stress, JNK and NF-κB activation, and inflammatory response. Inhibition of ER stress by 4-phenylbutyrate (4-PBA) or blockade of JNK activity by specific inhibitor or transfection of DN-JNK attenuated HG-induced inflammation and associated apoptosis. To validate the in vitro finding, in vivo application of 4-PBA resulted in a significant reduction of diabetes-induced neuronal ER stress, inflammation and cell death, leading to the prevention of DEP. These results suggest that diabetes-induced neuronal ER stress plays the critical role for diabetes-induced neuronal inflammation and cell death, leading to the development of DEP.
Keywords:
ER stress; apoptosis; diabetes; inflammation; p-JNK.
MeSH terms
-
Activating Transcription Factor 6 / metabolism
-
Animals
-
Anti-Inflammatory Agents / pharmacology
-
Apoptosis* / drug effects
-
Behavior, Animal
-
Brain Diseases / etiology*
-
Brain Diseases / metabolism
-
Brain Diseases / pathology
-
Brain Diseases / prevention & control
-
Cells, Cultured
-
Cognition
-
Diabetes Mellitus, Experimental / complications*
-
Diabetes Mellitus, Experimental / drug therapy
-
Diabetes Mellitus, Experimental / metabolism
-
Diabetes Mellitus, Experimental / pathology
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetes Mellitus, Type 2 / metabolism
-
Diabetes Mellitus, Type 2 / pathology
-
Dose-Response Relationship, Drug
-
Endoplasmic Reticulum Stress* / drug effects
-
Heat-Shock Proteins / metabolism
-
Hippocampus / drug effects
-
Hippocampus / metabolism
-
Hippocampus / pathology*
-
Interleukin-6 / metabolism
-
JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
JNK Mitogen-Activated Protein Kinases / genetics
-
JNK Mitogen-Activated Protein Kinases / metabolism
-
NF-kappa B / metabolism
-
Neurons / drug effects
-
Neurons / metabolism
-
Neurons / pathology*
-
Phosphorylation
-
Protein Kinase Inhibitors / pharmacology
-
Rats, Sprague-Dawley
-
Signal Transduction
-
Time Factors
-
Transcription Factor CHOP / metabolism
-
Transfection
-
Tumor Necrosis Factor-alpha / metabolism
-
X-Box Binding Protein 1 / metabolism
Substances
-
Activating Transcription Factor 6
-
Anti-Inflammatory Agents
-
Atf6 protein, rat
-
Ddit3 protein, rat
-
GRP78 protein, rat
-
Heat-Shock Proteins
-
Interleukin-6
-
NF-kappa B
-
Protein Kinase Inhibitors
-
Tumor Necrosis Factor-alpha
-
X-Box Binding Protein 1
-
Xbp1 protein, rat
-
Transcription Factor CHOP
-
JNK Mitogen-Activated Protein Kinases